BioSpace News Archive

International Study at MD Anderson Sister Institutions Supports Mino Lok Phase IIb Results: Poster Presented at ID Week

The 44 patient study, was conducted in Brazil, Lebanon, and Japan and showed Mino Lok therapy was an effective intervention to salvage long term, infected CVCs in catheter related bloodstream infections in patients who had cancer with limited vascular access.

November 7, 2017

·

4 min read

Business

Unchained Labs Drifts Into Tokyo, Opens New Office in Japan

The new Tokyo office, right in the heart of the city, is Unchained Labs’ 6th office worldwide.

November 7, 2017

·

1 min read

Drug Development

Nektar Therapeutics Presents Preclinical Data on NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 2017 American College of Rheumatology Annual Meeting

NKTR-358 is a novel immunological therapy designed to target the interleukin receptor complex in the body in order to stimulate proliferation of powerful inhibitory immune cells known as regulatory T cells.

November 7, 2017

·

7 min read

Business

Audentes Therapeutics to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 14, 2017

The conference call will be held at 4:30 p.m. ET, after the market closes.

November 7, 2017

·

1 min read

Business

Cardiome to Hold Third Quarter 2017 Financial Results Conference Call on November 14

Cardiome will hold a conference call and webcast at 4:30 p.m. Eastern on that day to discuss the results.

November 7, 2017

·

5 min read

Business

Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results

n August, Infinity announced that the company designated the 60 mg QD dose for evaluation in the monotherapy expansion component of the study, which is now under way.

November 7, 2017

·

19 min read

Drug Development

Results From Alligator Bioscience’s Clinical Phase I Study Support Further Clinical Development of ADC-1013

The study results show that ADC-1013 is generally well tolerated and support further clinical development of ADC-1013 as a mono- or combination therapy.

November 7, 2017

·

5 min read

Biotech Bay

Splunk Machine Learning Helps Recursion Pharmaceuticals Treat Genetic Diseases

With Splunk, Recursion has combined biological science with machine learning to generate and analyze data from tens of thousands of images of cell cultures and trillions of DNA strands.

November 7, 2017

·

4 min read

Business

Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer

Dr. McNiece has spent 30 years in both academic and commercial settings working in the areas of stem cell biology and clinical manufacturing for bone marrow transplantation and cellular therapy clinical applications.

November 7, 2017

·

4 min read

Biotech Beach

Oska Pulse Wearable Pain Relief Device Now Available on Amazon

“For people living with chronic and acute pain, the availability of Oska Pulse at the world’s foremost online retail outlet will offer additional access to our non-drug, non-invasive pain relief technology.”

November 7, 2017

·

2 min read